Larvol Delta - Intravenous-Iloprost-in-Subjects-With-Symptomatic-Raynaud39s-Phenomenon-Secondary-to-Systemic-Sclerosis-Phase-3

iloprost intravenous (CIVI030) - CiVi Biopharma

http://clinicaltrials.gov/ct2/show/NCT04040322

Jul 14, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next